Research Use Only. Retatrutide is sold as a chemical reagent for in-vitro laboratory research, not for human or veterinary use. It is not a drug, supplement, or compounded preparation. It must be handled by qualified professionals. Wholesale Peptide Supply is not a pharmacy or compounding facility under 503A or 503B.
Wholesale Retatrutide — Bulk Research Supply
Available sizes
In-stock orders ship same day when paid by 1 pm PT, Mon–Fri. Overnight available.
Buy Retatrutide wholesale and in bulk from a US-based research peptide supplier. Every lot is sourced in the USA and third-party tested, with the lab and method on each lot's certificate. Bulk Retatrutide is quoted by dose and volume from a 3-kit (30-vial) order minimum, mix and match across doses and compounds; volume pricing is earned at 100 kits in the order.
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
Orders start at 3 kits (30 vials), mix and match: from $663.18 in 10mg.
Wholesale Catalog
Available Doses
Published per-vial wholesale pricing for Retatrutide. Sold in kits of 10 vials with a 3-kit (30-vial) order minimum, mix and match across doses and compounds; volume pricing applies at 1,000+ vials. Contact us for larger or custom-volume quotes — answered the same day. Urgent? Text or call (714) 625-9215 — you’ll reach a real person in the United States, not a chatbot or an overseas call center.
Retatrutide 10mg
WPSRT10 · CAS 2381089-83-2 · GLP-1 & Metabolic
- 1–9 kits
- $22.11/vial$19.90 paying by card
- 10–99 kits
- $17.69/vial$15.92 paying by card
- 100+ kits
- $14.15/vial$12.73 paying by card
10% off with card Every product, every volume band — taken off at checkout when you choose card.
Sold in kits of 10 vials · 3-kit order minimum, mix and match · price set by the total kits in your order (BAC water not counted)
Retatrutide 30mg
WPSRT30 · CAS 2381089-83-2 · GLP-1 & Metabolic
- 1–9 kits
- $45.86/vial$41.27 paying by card
- 10–99 kits
- $36.69/vial$33.02 paying by card
- 100+ kits
- $29.35/vial$26.41 paying by card
10% off with card Every product, every volume band — taken off at checkout when you choose card.
Sold in kits of 10 vials · 3-kit order minimum, mix and match · price set by the total kits in your order (BAC water not counted)
Retatrutide 60mg
WPSRT60 · CAS 2381089-83-2 · GLP-1 & Metabolic
- 1–9 kits
- $68.28/vial$61.45 paying by card
- 10–99 kits
- $54.63/vial$49.16 paying by card
- 100+ kits
- $43.70/vial$39.33 paying by card
10% off with card Every product, every volume band — taken off at checkout when you choose card.
Sold in kits of 10 vials · 3-kit order minimum, mix and match · price set by the total kits in your order (BAC water not counted)
Retatrutide 20mg
WPSRT20 · CAS 2381089-83-2 · GLP-1 & Metabolic
- 1–9 kits
- $30.19/vial$27.17 paying by card
- 10–99 kits
- $24.15/vial$21.74 paying by card
- 100+ kits
- $19.32/vial$17.39 paying by card
10% off with card Every product, every volume band — taken off at checkout when you choose card.
Sold in kits of 10 vials · 3-kit order minimum, mix and match · price set by the total kits in your order (BAC water not counted)
Overview
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
History
Builds on decades of single- and dual-agonist research; uniquely integrates three pathway targets.
Structure and mechanism
Retatrutide is a synthetic peptide engineered as a triple agonist — active at three distinct receptor targets simultaneously — representing the current frontier of multi-pathway metabolic research compounds. It extends the design logic of single-pathway (semaglutide) and dual-pathway (tirzepatide) agonists by integrating a third pathway, glucagon-receptor activity, alongside the two.
In preclinical laboratory models the compound is studied for the broad, multi-system signaling that arises from co-activating three pathways, and it is frequently used as the reference point in triple- vs. dual-agonist comparative work. Its molecular weight (4,845.44 g/mol) and formula (C₂₂₁H₃₄₂N₄₆O₆₈) sit close to tirzepatide's, but its receptor-engagement profile is distinct.
Reconstitution and handling (research use)
Wholesale retatrutide ships as a lyophilized powder. For in-vitro laboratory use it is reconstituted with bacteriostatic or sterile water, with diluent volume chosen to reach the assay's target concentration. Lyophilized material is generally stored at -20°C and protected from light; reconstituted solution is refrigerated at 2–8°C and used within the working window the study defines.
These notes cover general laboratory handling of a chemical reagent only — not human or veterinary use.
Wholesale sourcing notes
Retatrutide is among the fastest-growing compounds in wholesale research demand, stocked in 10 mg and higher presentations. Every lot is US-sourced and independently verified by a third-party lab for identity, purity, and quantitation, with a per-lot COA included in every order.
Pricing is quoted by volume across 100, 250, 500, and 1,000-vial bands under a 3-kit (30-vial) minimum per order, mix and match, with a lower price band unlocking at 1,000 vials across the whole order.
Certificates of Analysis
16 certificates are on file for Retatrutide — open any one to read the full report.
| Lot / Lab | Dose | Tested | Purity | Certificate |
|---|---|---|---|---|
| WPS-GLR20-20260915-01pH Solutions LabHPLC-UV | 20mg | 2026-10-07 | 99% | |
| WPS-GLR30-20260915-01pH Solutions LabHPLC-UV | 30mg | 2026-10-07 | 99% | |
| DPS-4764326Horizon AnalyticalUPLC/MS | 10mg | 2026-10-03 | 99.55%Endotoxin <0.05 EU/mL | |
| DPS-3766704Horizon AnalyticalUPLC/MS | 20mg | 2026-09-14 | 99.61%Endotoxin <0.05 EU/mL | |
| 100089-0944Optiq Health LabsRP-HPLC / LC-MS | 10mg | 2026-08-20 | — | |
| 100089-0945Optiq Health LabsRP-HPLC / LC-MS | 20mg | 2026-08-20 | — | |
| 100089-0946Optiq Health LabsRP-HPLC / LC-MS | 30mg | 2026-08-20 | — | |
| 100089-0947Optiq Health LabsRP-HPLC / LC-MS | 60mg | 2026-08-20 | — | |
| 100057-0611Optiq Health LabsRP-HPLC / LC-MS | 20mg | 2026-08-05 | — | |
| 100057-0612Optiq Health LabsRP-HPLC / LC-MS | 40mg | 2026-08-05 | — | |
| 100057-0613Optiq Health LabsRP-HPLC / LC-MS | 60mg | 2026-08-05 | — | |
| 100032-0310Optiq Health LabsRP-HPLC / LC-MS | 10mg | 2026-07-29 | — | |
| 100032-0317Optiq Health LabsRP-HPLC / LC-MS | 20mg | 2026-07-29 | — | |
| 100032-0300Optiq Health LabsRP-HPLC / LC-MS | 30mg | 2026-07-29 | — | |
| 100032-0304Optiq Health LabsRP-HPLC / LC-MS | 60mg | 2026-07-29 | — | |
| 100031-0284Optiq Health LabsRP-HPLC | 30mg | 2026-07-27 | — |
Key Areas of Research
- Receptor binding and cascades
- Pathway subtypes and modulation
- Vascular lipid pathways
- Multi-system signaling
- Triple- vs. dual-agonist comparative studies
References
- Jastreboff A.M. et al. (2023). Triple-hormone-receptor agonist retatrutide for obesity. NEJM 389:514–526.
- Coskun T. et al. (2022). LY3437943 triple agonist. Mol Metabol 69:101470.
- Rosenstock J. et al. (2023). Retatrutide, a GIP/GLP-1/glucagon receptor agonist. Lancet, 402(10401):529–544.
Retatrutide — Frequently Asked Questions
- What is Retatrutide?
- Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
- What is the CAS number for Retatrutide?
- The CAS number for Retatrutide is 2381089-83-2. Its molecular formula is C₂₂₁H₃₄₂N₄₆O₆₈ (MW 4,845.44 g/mol).
- What doses of Retatrutide are available wholesale?
- Wholesale Peptide Supply stocks Retatrutide in 10mg, 30mg, 60mg, 20mg. Wholesale pricing is provided by quote based on order volume, from a 3-kit (30-vial) order minimum, mix and match across doses and compounds.
- Is Retatrutide third-party tested?
- Yes. Every lot of Retatrutide is tested by an independent third-party laboratory, and a per-lot Certificate of Analysis documenting identity and purity is included with every order at no charge, issued in the name of Wholesale Peptide Supply. The most recent published lot, WPS-GLR20-20260915-01 (20mg), was tested by pH Solutions Lab on 7 October 2026 by HPLC-UV: purity 99%. Every lot on file is listed with its certificate on this page.
- Is Retatrutide for human use?
- No. Retatrutide is sold strictly as a chemical reagent for in-vitro laboratory research and is not for human or veterinary use. Wholesale Peptide Supply is not a pharmacy or compounding facility.
- How do I get wholesale pricing for Retatrutide?
- Request a quote through our contact form or open a wholesale account. An account manager replies with volume pricing and lead times the same day. For anything urgent, text or call (714) 625-9215 to reach a real person in the US.
- Can I order Retatrutide in bulk?
- Yes. Retatrutide is available for bulk and wholesale orders, quoted by dose and volume, with the lower price earned at 100 kits (1,000 vials) in the order. Submit the doses and quantities you need for a bulk quote.
- How does retatrutide compare to tirzepatide and semaglutide?
- Retatrutide is a triple-pathway agonist (three receptor targets), tirzepatide is dual-pathway, and semaglutide is single-pathway. All three are distinct research compounds and are not interchangeable in laboratory models; retatrutide is the newest and is commonly used as the reference in triple-agonist comparative studies.
- Is wholesale retatrutide third-party tested?
- Yes. Every lot of retatrutide is US-sourced and independently tested by a third-party lab, confirming identity, purity, and quantitation. A per-lot Certificate of Analysis is included with every order at no charge.
Related Compounds
GLP-1 & Metabolic
Semaglutide
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
View details →GLP-1 & Metabolic
Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
View details →GLP-1 & Metabolic
Cagrilintide
Cagrilintide is a synthetic, long-acting analog of amylin, studied for activation of target receptor pathways and characterization of endocrine and neuroendocrine signaling.
View details →GLP-1 & Metabolic
AOD-9604
AOD-9604 is a synthetic peptide fragment derived from the C-terminus of the somatotropin sequence, studied for its effects on lipolytic and anti-lipogenic pathways and β3-adrenergic signaling.
View details →GLP-1 & Metabolic
HGH Fragment 176-191
HGH Fragment 176-191 is the C-terminal 16-residue fragment of human growth hormone, carrying an intramolecular disulfide bridge. It is studied in laboratory models of lipolytic signaling separated from the growth-promoting activity of the full hormone.
View details →GLP-1 & Metabolic
Triple Antagonist Liquid Spray
A combined metabolic research solution supplied as an atomized solution in a metered spray bottle. Composition is stated on the certificate of analysis for each lot.
View details →Secretagogue Peptides
Ipamorelin
Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist with minimal off-target pathway interference, used to study endocrine signaling and somatotroph axis modulation.
View details →Recovery & Structural
BPC-157
BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, originally derived from a naturally occurring protein fragment in gastric tissue. It has been studied extensively for its potential influence on molecular signaling, structural remodeling, and angiogenic processes.
View details →